CU6 clarity pharmaceuticals ltd

In the November 2024 Earnings call, Lantheus mentioned losing...

  1. 1,125 Posts.
    lightbulb Created with Sketch. 1311
    In the November 2024 Earnings call, Lantheus mentioned losing some clients to Illuccix. Their explanation was that these were customers that were more focussed on price and less about quality. Lantheus were not concerned about those accounts as they were small and Lantheus were focused on larger ones (to my recollection).

    The earnings from Pylarify have continued to go down, leading not just to them missing estimates in the May 2025 earnings, but actually decreasing when over time. I find it strange that they now cite future competition, even including competitors that are yet to arrive after 2026! How can that be, if the TAM is growing, and as we know from Telix, Illuccix is growing into it?

    Lantheus is failing to execute.
    They are spending money poorly.
    They look to be in serious trouble.



    Last edited by ttppxx: 09/05/25
 
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)
Last
$4.33
Change
0.000(0.00%)
Mkt cap ! $1.400B
Open High Low Value Volume
$4.31 $4.44 $4.20 $11.74M 2.723M

Buyers (Bids)

No. Vol. Price($)
1 5000 $4.31
 

Sellers (Offers)

Price($) Vol. No.
$4.34 132 1
View Market Depth
Last trade - 16.16pm 30/07/2025 (20 minute delay) ?
CU6 (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.